Welcome to Episode 8 (S2): Chronic Inflammation
Did you know that 3 out of 5 people are affected by chronic inflammation?
It's a staggering statistic that touches so many lives, and in this episode, we're diving deep into the world of chronic inflammation.
If you're passionate about precision medicine, consider this episode a must-listen. We're concluding our second season with a masterclass that explores the complexities of chronic inflammation.
Our host, Ariadna Maso, engages in an enlightening conversation with two remarkable guests: AVENNA's CEO, Nina Skorytchenko, and Project Manager, Cindy Weiss.
AVENNA, a pioneering biotech company, is at the forefront of early detection and personalized treatment for chronic inflammatory diseases. Their mission is to translate cutting-edge research into predictive models and bring blood glycomic biomarkers for inflammatory bowel, brain, and skin diseases to market.
Here's a glimpse of what we'll uncover in this episode:
Tune in now and let's embark on this insightful journey into the world of chronic inflammation!
If you find this episode as illuminating as we do, we kindly invite you to leave a review (hopefully 5 stars!) and share it with friends 🌟
For any feedback or enquiries, please get in touch at hello@sanno.health
Follow us on instagram at sanno.health
Tweet us at @sanno_health
See you on the Sanno app! Free download here: iOS/ Android
Welcome to Episode 8 (S2): Chronic Inflammation
Did you know that 3 out of 5 people are affected by chronic inflammation?
It's a staggering statistic that touches so many lives, and in this episode, we're diving deep into the world of chronic inflammation.
If you're passionate about precision medicine, consider this episode a must-listen. We're concluding our second season with a masterclass that explores the complexities of chronic inflammation.
Our host, Ariadna Maso, engages in an enlightening conversation with two remarkable guests: AVENNA's CEO, Nina Skorytchenko, and Project Manager, Cindy Weiss.
AVENNA, a pioneering biotech company, is at the forefront of early detection and personalized treatment for chronic inflammatory diseases. Their mission is to translate cutting-edge research into predictive models and bring blood glycomic biomarkers for inflammatory bowel, brain, and skin diseases to market.
Here's a glimpse of what we'll uncover in this episode:
Tune in now and let's embark on this insightful journey into the world of chronic inflammation!
If you find this episode as illuminating as we do, we kindly invite you to leave a review (hopefully 5 stars!) and share it with friends 🌟
For any feedback or enquiries, please get in touch at hello@sanno.health
Follow us on instagram at sanno.health
Tweet us at @sanno_health
See you on the Sanno app! Free download here: iOS/ Android